Roche bets again on Ionis in Huntington’s, Alzheimer’snews2023-09-27T13:21:56+00:00September 27th, 2023|Endpoints News|
Microsoft’s Nuance launches DAX Copilot to more clinicians for AI-assisted medical notesnews2023-09-27T13:00:25+00:00September 27th, 2023|Endpoints News|
Sitryx locks an additional $39M in a Series A raise to advance its immunometabolic pipeline into clinicnews2023-09-27T11:36:51+00:00September 27th, 2023|Endpoints News|
VBI Vaccines’ pan-coronavirus vaccine disappoints in PhI studynews2023-09-27T11:30:37+00:00September 27th, 2023|Endpoints News|
Exclusive: Komodo is betting that its MapLab tool can upend how healthcare data are analyzednews2023-09-27T11:00:15+00:00September 27th, 2023|Endpoints News|
CellFE raises $22M Series A to advance cell therapy microfluidics manufacturingnews2023-09-27T11:00:02+00:00September 27th, 2023|Endpoints News|
Galecto lays off 29 employees, considers strategic alternatives after flunking lung fibrosis trialnews2023-09-27T10:41:30+00:00September 27th, 2023|Endpoints News|
Avalyn raises $175M to test inhaler versions of IPF medicines in PhII trialsnews2023-09-27T10:30:28+00:00September 27th, 2023|Endpoints News|
AbbVie drops Caribou partnership on gene-edited CAR-T therapynews2023-09-26T21:04:58+00:00September 26th, 2023|Endpoints News|
European Commission approves first biosimilar for MS drug Tysabrinews2023-09-26T19:21:56+00:00September 26th, 2023|Endpoints News|
